Profusa, Inc. Common Stock
PFSAStock
$1.86−99.95%52W
Market Cap$1.00M
P/E—
Div yield—
Beta0.60
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-107.62%
Price vs S&P 500 (4W)-65.59%
VGM Score1.33
Market Capitalization$1.00M
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PFSAProfusa, Inc. Common Stock | — | — | F | $1.86 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Profusa is a clinical-stage medical technology company developing implantable biosensors designed to integrate with the body and continuously transmit clinical-grade health data. The company's technology enables real-time monitoring of biomarkers for various diseases and conditions. Its lead product, the Lumee Oxygen Platform, is available in the European Union and measures tissue oxygen levels for both acute and long-term patient monitoring.